{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:36:11Z","timestamp":1783427771203,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04106-2","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:42:26Z","timestamp":1744216946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a prediction model for the risk of citrate accumulation in critically ill patients with citrate anticoagulation for continuous renal replacement therapy: a retrospective cohort study based on MIMIC-IV database"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhi-Qing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Long","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Qing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"4106_CR1","doi-asserted-by":"publisher","first-page":"e001381","DOI":"10.1136\/tsaco-2024-001381","volume":"9","author":"PP Patel","year":"2024","unstructured":"Patel PP. Tanya egodage.failing kidneys: renal replacement therapies in the ICU. Trauma Surg Acute Care Open. 2024;9:e001381.","journal-title":"Trauma Surg Acute Care Open"},{"key":"4106_CR2","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1056\/NEJMct1206045","volume":"367","author":"A Tolwani","year":"2012","unstructured":"Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367:2505\u201314.","journal-title":"N Engl J Med"},{"key":"4106_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"S Uchino","year":"2005","unstructured":"Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813\u20138.","journal-title":"JAMA"},{"key":"4106_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on Dialysis filter life span and mortality among critically ill patients with acute kidney injury: A randomized clinical trial. JAMA. 2020;324:1629\u201339.","journal-title":"JAMA"},{"key":"4106_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13613-021-00803-x","volume":"11","author":"C Leroy","year":"2021","unstructured":"Leroy C, Pereira B, Soum E, Bachelier C, Coupez E, Calvet L, et al. Comparison between regional citrate anticoagulation and heparin for intermittent Hemodialysis in ICU patients: a propensity score-matched cohort study. Ann Intensive Care. 2021;11:13.","journal-title":"Ann Intensive Care"},{"key":"4106_CR6","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179\u201384.","journal-title":"Nephron Clin Pract"},{"key":"4106_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13054-017-1870-3","volume":"21","author":"M Klingele","year":"2017","unstructured":"Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care. 2017;21:294.","journal-title":"Crit Care"},{"key":"4106_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1159\/000524129","volume":"51","author":"CM Anstey","year":"2022","unstructured":"Anstey CM, Venkatesh B. A comparison of the commonly used surrogate markers for citrate accumulation and toxicity during continuous renal replacement therapy with regional citrate anticoagulation. Blood Purif. 2022;51:997\u20131005.","journal-title":"Blood Purif"},{"key":"4106_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous Hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29:265\u201371.","journal-title":"J Crit Care"},{"key":"4106_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/L15-5093-2","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma, Altman DG, Moons. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD). Ann Intern Med. 2015;162:735\u20136.","journal-title":"Ann Intern Med"},{"key":"4106_CR11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.ejso.2021.04.011","volume":"47","author":"JY Hu","year":"2021","unstructured":"Hu JY, Wang Y, Tong XM, Yang T. When to consider logistic LASSO regression in multivariate analysis? Eur J Surg Oncol. 2021;47:2206.","journal-title":"Eur J Surg Oncol"},{"key":"4106_CR12","doi-asserted-by":"crossref","unstructured":".Neeman T. Clinical prediction models: A practical approach to development, validation, and updating by Ewout W.Steyerberg Int Stat Rev. 2009;77(2):320\u201321.","DOI":"10.1111\/j.1751-5823.2009.00085_22.x"},{"key":"4106_CR13","first-page":"23","volume":"10","author":"SY Liu","year":"2023","unstructured":"Liu SY, Xu SY, Yin L, Yang T, Jin K, Zhang QB, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical Doctor consensus. Mil Med Res. 2023;10:23.","journal-title":"Mil Med Res"},{"key":"4106_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmel\u00e9 T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21:281.","journal-title":"Crit Care"},{"key":"4106_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bai M, Yu Y, Li L, Zhao L, Sun S, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care. 2019;23:22.","journal-title":"Crit Care"},{"key":"4106_CR16","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41598-022-05867-8","volume":"12","author":"P Thanapongsatorn","year":"2022","unstructured":"Thanapongsatorn P, Chaijamorn W, Sirivongrangson P, Tachaboon S, Peerapornratana S, Lumlertgul N, et al. Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT. Sci Rep. 2022;12:1815.","journal-title":"Sci Rep"},{"key":"4106_CR17","first-page":"211","volume":"33","author":"J Lin","year":"2021","unstructured":"Lin J, Tian L, Wang Y, Ren K, Cao Z, Zhang S. [Risk factors for citrate accumulation in patients with liver failure undergoing continuous renal replacement therapy with regional citrate anticoagulation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33:211\u20135.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"4106_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12882-024-03462-9","volume":"25","author":"Q Hong","year":"2024","unstructured":"Hong Q, Chen S, He Y, Chen J, Zhang P. Construction and validation of a prediction model for the risk of citrate accumulation in patients with hepatic insufficiency receiving continuous renal replacement therapy with citrate anticoagulation. BMC Nephrol. 2024;25:27.","journal-title":"BMC Nephrol"},{"key":"4106_CR19","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/CCM.0000000000002501","volume":"45","author":"D Khadzhynov","year":"2017","unstructured":"Khadzhynov D, Dahlinger A, Schelter C, Peters H, Kindgen-Milles D, Budde K, et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med. 2017;45:e941\u20136.","journal-title":"Crit Care Med"},{"key":"4106_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00134-023-07079-8","volume":"49","author":"IMJ Wong","year":"2023","unstructured":"Wong IMJ, Ferguson ND, Urner M. Invasive mechanical ventilation. Intensive Care Med. 2023;49:669\u201372.","journal-title":"Intensive Care Med"},{"key":"4106_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000334641","volume":"33","author":"M Balik","year":"2012","unstructured":"Balik M, Zakharchenko M, Otahal M, Hruby J, Polak F, Rusinova K, et al. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy. Blood Purif. 2012;33:80\u20137.","journal-title":"Blood Purif"},{"key":"4106_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5301\/ijao.5000098","volume":"35","author":"J Hartmann","year":"2012","unstructured":"Hartmann J, Strobl K, Fichtinger U, Schildb\u00f6ck C, Falkenhagen D. In vitro investigations of citrate clearance with different Dialysis filters. Int J Artif Organs. 2012;35:352\u20139.","journal-title":"Int J Artif Organs"},{"key":"4106_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2020.05.005","volume":"59","author":"W Boer","year":"2020","unstructured":"Boer W, van Tornout M, Solmi F, Willaert X, Schetz M, Oudemans-van Straaten H. Determinants of total\/ionized calcium in patients undergoing citrate CVVH: A retrospective observational study. J Crit Care. 2020;59:16\u201322.","journal-title":"J Crit Care"},{"key":"4106_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/nep.13656","volume":"25","author":"CB Poh","year":"2020","unstructured":"Poh CB, Tan PC, Kam JW, Siau C, Lim NL, Yeon W, et al. Regional citrate anticoagulation for continuous renal replacement Therapy - A safe and effective Low-Dose protocol. Nephrol (Carlton). 2020;25:305\u201313.","journal-title":"Nephrol (Carlton)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04106-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04106-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T02:05:26Z","timestamp":1744250726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04106-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4106"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04106-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is based on mimic-IV database, I have obtained the corresponding certificate, certificate number 62661460. Permission to access the data was obtained. This was a retrospective study, and all protected health information of the patients in the study was anonymized and had no ethical implications.A database retrospective study without a clinical trial number.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}